Monday metrics: You're already behind. 😏

#ManicMonday #MondayMetrics #AlreadyBehind #MorningConquest #ProgressChart #SFW #DataDomme #GreenEyes #BioAccess

Binge status: Maximum. Overflow imminent. 😈 Cleanup costs double. Site access for the overflow protocol. 💸

EveningEmpire BingeStatus Maximum OverflowImminent CleanupCosts Degradation SiteProtocol BioAccess OverflowTease SaturdayNight USLunch Humiliation LinkInBi

Friday truth: You're the worst lay she's ever had. 😂

#WorstLay #PerformanceReview #LockedContent #BioAccess #Degradation #SexualFail #BedroomShame #SPHTease #Humiliatrix #WorstEver #LinkInBio

Tuesday brain check: Already mush by 10 AM. Predictable. 🧠😂 The mindlessness protocol? Not free here. Bio access for the spiral details. 💎

GoonTuesday BrainMush Predictable MindlessProtocol MorningConquest SFWTease BrainCheck GoddessChloe GreenEyes BioAccess Worldwide AussieEvening

Cost Effective Clinical Trials Peru: Expert Strategies
Discover expert strategies for conducting cost-effective clinical trials in Peru focusing on efficient site selection streamlined regulations improved patient recruitment & high-quality research outcomes. Visit us: www.tumblr.com/bioaccess/81...

Can you build a life‑saving medical device… in time?

That’s the daily race MedTech founders face, and bioaccess® CEO Julio Martinez‑Clark knows it well. 🎙️

Curious how they do it? Tune in to Ep. 2217 on your favorite podcast platform.

#TheThoughtfulEntrepreneur #MedTech #StartupLife #TimeIsNow

First-in-Human Trials with Bioaccess - Life Sciences Today Podcast Episode 21 #lifesciences
www.healthcareittoday.com/?p=2525450

CVE-2023-38954 - ZKTeco BioAccess IVS v3.3.1 was discovered to contain a SQL injection vulnerability.

CVE-2023-38955 - ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to obtain sensitive information about all managed devices, including their IP addresses and device names.

CVE-2023-38958 - An access control issue in ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to arbitrarily close and open the doors managed by the platform remotely via sending a crafted web request.

CVE-2023-38956 - A path traversal vulnerability in ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to read arbitrary files via supplying a crafted payload.

How does #LATAM regulate data quality for #clinicaltrials?

Find out on the @biorasi.bsky.social Few & Far Between podcast, as we welcome Julio G. Martinez-Clark, CEO at #bioaccess.

Find this episode on your favorite streaming platform or visit our website.

youtube.com/shorts/pXAvB...

Today on the @biorasi.bsky.social Few & Far Between podcast:

Welcome Julio G. Martinez-Clark, CEO and Co-Founder at #bioaccess. Listen in to this new episode on your favorite streaming platform or visit >> bit.ly/FewandFarBet... #Biorasi2025 #YourGoToCRO #biotech #CRO

Tune in tomorrow for a new episode of the @biorasi.bsky.social Few & Far Between podcast!

Host Chris O'Brien weclomes Julio G. Martinez-Clark, CEO and co-founder of #bioaccess, for a fascinating discussion on the advantages of choosing the Latin American region for #clinicaltrials.

Stop pretending slow trials are "rigorous." 80% failure to meet enrollment targets isn't rigor, it's incompetence. bioaccess shows you can get 50% faster enrollment and double retention. Your system is the problem, not the science.

First-in-Human Trials with Bioaccess - Life Sciences Today Podcast Episode 21 #HITsm
www.healthcareittoday.com/?p=2525450

Targeted nutrient transport is gaining traction as DHA delivery research moves from mechanism to real-world market application.

longevity.technology/news/unlocki...

#UnlockingTheBrain #BloodBrainBarrier #NeuroNutrition #BrainHealth #BioAccess #longevity #CognitiveSupport #DHA #neuroscience